Yahoo Finance • last month
Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider tra... Full story
Yahoo Finance • 6 months ago
SAN DIEGO, May 23, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and tran... Full story
Yahoo Finance • 9 months ago
In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now.... Full story
Yahoo Finance • 9 months ago
Revenue: QuidelOrtho Corp (NASDAQ:QDEL) reported a decrease in total revenue to $743 million in Q4 2023, down from $867 million in the prior year period. Net Income: GAAP net income for Q4 2023 was $7 million, with diluted earnings per sha... Full story
Yahoo Finance • last year
SAN DIEGO, November 16, 2023--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion med... Full story
Yahoo Finance • 2 years ago
The top healthcare stocks include Azenta Inc. for best value, McKesson Corp. for fastest growth, and Signify Health Inc. for most momentum. Continue reading... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for its second quarter 2022 ended July 3, 2022,... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics H... Full story
Yahoo Finance • 3 years ago
RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a... Full story